Jul 6, 2021 09:02AM
Jul 6, 2021 09:00AM
May 25, 2021 09:12AM
May 25, 2021 09:00AM
May 7, 2021 09:15AM
May 7, 2021 09:05AM
Apr 13, 2021 07:45AM Auris Medical (EARS) Announces Positive Preclinical and Clinical Outcomes with AM-301 and Details Plans for Market Launch
Apr 13, 2021 07:45AM
Mar 31, 2021 08:30AM
Sep 17, 2020 08:05AM
Sep 17, 2020 08:00AM
Sep 8, 2020 08:38AM
Sep 8, 2020 08:30AM
Apr 16, 2020 07:00AM Auris Medical Provides Business Update and Reports Second Half and Full Year 2019 Financial Results
Sep 13, 2019 09:00AM
Aug 15, 2019 07:00AM
May 23, 2019 09:00AM
Apr 25, 2019 09:06AM
Apr 25, 2019 09:00AM
Mar 14, 2019 07:00AM
Mar 11, 2019 08:51AM Auris Medical Holding (EARS) Announces Publication of AM-111 Phase 3 Results in Otology & Neurotology
Mar 11, 2019 04:51AM
Jan 15, 2019 08:31AM
Nov 20, 2018 09:27AM
Nov 20, 2018 09:20AM
Nov 15, 2018 06:45AM
Aug 30, 2018 08:17AM
Aug 30, 2018 08:16AM Auris Medical Receives FDA Guidance at Type C Meeting for AM-111 in the Treatment of Sudden Sensorineural Hearing Loss
Aug 15, 2018 06:45AM
May 15, 2018 06:45AM
May 7, 2018 07:38AM
May 7, 2018 07:30AM
Mar 22, 2018 09:05AM
Mar 14, 2018 09:22AM
Jan 4, 2018 08:30AM Auris Medical Provides Update on AM-111 Development Program
Nov 28, 2017 06:40AM
Aug 10, 2017 06:31AM
Jul 20, 2017 08:01AM
Jul 5, 2017 08:02AM
Jul 5, 2017 08:01AM
May 11, 2017 06:16AM
May 9, 2017 08:01AM Auris Medical Reports Key Results from Keyzilen® AMPACT1 Open-Label Extension Study
Apr 24, 2017 08:05AM
Apr 24, 2017 08:01AM
Mar 14, 2017 08:42AM
Mar 14, 2017 06:01AM
Feb 24, 2017 08:01AM
Feb 24, 2017 08:00AM
Feb 3, 2017 06:31AM Auris Medical Expands Clinical Development Pipeline with Intranasal Betahistine for the Treatment of Meniere's Disease and Vestibular Vertigo

322,902 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All